Literature DB >> 21835759

A novel mutation in transforming growth factor-beta induced protein (TGFβIp) reveals secondary structure perturbation in lattice corneal dystrophy.

Rajamani Lakshminarayanan1, Eranga N Vithana, Shu-Ming Chai, Shyam S Chaurasia, Padhmanaban Saraswathi, Anandalaksmi Venkatraman, Camille Rojare, Divya Venkataraman, Donald Tan, Tin Aung, Roger W Beuerman, Jodhbir S Mehta.   

Abstract

BACKGROUND: To describe mutations in the transforming growth factor-beta induced (TGFBI) gene in Asian patients with Bowman's membrane as well as stromal corneal dystrophies, and to elucidate their structural implications, using model peptides.
METHODS: Twenty-two unrelated Asian families were examined clinically including visual acuity testing and ocular examination with slit lamp biomicroscopy. Genomic DNA was extracted and the 17 exons of the TGFBI gene were amplified by PCR and sequenced bi-directionally. Biophysical techniques were used to characterise the wild type and mutant model peptides.
RESULTS: Molecular genetic analysis identified a variety of mutations in our patient series including a novel heterozygous C to A transversion mutation in exon 14 (c.1859C→A), resulting in a substitution of a highly conserved alanine residue by aspartic acid (p.A620D). Clinical presentation in the patient with the p.A620D included subepithelial scarring in addition to the linear branching opacities usually seen with lattice dystrophy. Using model peptides, we showed that A620D mutant peptide alters the secondary structure and conformational stability, and increased amyloid formation.
CONCLUSION: A novel mutation (A620D) in transforming growth factor-beta induced protein (TGFβIp) is described, expanding the repertoire of mutations in this protein. Using model peptides, we demonstrated that A→D substitution leads to perturbation of the secondary structure that may be responsible for the amyloid formation in lattice corneal dystrophy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835759     DOI: 10.1136/bjophthalmol-2011-300651

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  Global implementation of genomic medicine: We are not alone.

Authors:  Teri A Manolio; Marc Abramowicz; Fahd Al-Mulla; Warwick Anderson; Rudi Balling; Adam C Berger; Steven Bleyl; Aravinda Chakravarti; Wasun Chantratita; Rex L Chisholm; Vajira H W Dissanayake; Michael Dunn; Victor J Dzau; Bok-Ghee Han; Tim Hubbard; Anne Kolbe; Bruce Korf; Michiaki Kubo; Paul Lasko; Erkki Leego; Surakameth Mahasirimongkol; Partha P Majumdar; Gert Matthijs; Howard L McLeod; Andres Metspalu; Pierre Meulien; Satoru Miyano; Yaakov Naparstek; P Pearl O'Rourke; George P Patrinos; Heidi L Rehm; Mary V Relling; Gad Rennert; Laura Lyman Rodriguez; Dan M Roden; Alan R Shuldiner; Sukdeb Sinha; Patrick Tan; Mats Ulfendahl; Robyn Ward; Marc S Williams; John E L Wong; Eric D Green; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2015-06-03       Impact factor: 17.956

2.  Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.

Authors:  Charlotte S Sørensen; Kasper Runager; Carsten Scavenius; Morten M Jensen; Nadia S Nielsen; Gunna Christiansen; Steen V Petersen; Henrik Karring; Kristian W Sanggaard; Jan J Enghild
Journal:  Biochemistry       Date:  2015-05-06       Impact factor: 3.162

3.  Uncovering the profile of mutations of transforming growth factor beta-induced gene in Chinese corneal dystrophy patients.

Authors:  Xiao-Dan Hao; Yang-Yang Zhang; Peng Chen; Su-Xia Li; Ye Wang
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

4.  Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease.

Authors:  Kathleen A Christie; Louise J Robertson; Caroline Conway; Kevin Blighe; Larry A DeDionisio; Connie Chao-Shern; Amanda M Kowalczyk; John Marshall; Doug Turnbull; M Andrew Nesbit; C B Tara Moore
Journal:  Mol Ther       Date:  2020-05-08       Impact factor: 11.454

5.  Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.

Authors:  Venkatraman Anandalakshmi; Elavazhagan Murugan; Eunice Goh Tze Leng; Lim Wei Ting; Shyam S Chaurasia; Toshio Yamazaki; Toshio Nagashima; Benjamin Lawrence George; Gary Swee Lim Peh; Konstantin Pervushin; Rajamani Lakshminarayanan; Jodhbir S Mehta
Journal:  Biochem J       Date:  2017-05-09       Impact factor: 3.857

6.  Effect of osmolytes on in-vitro aggregation properties of peptides derived from TGFBIp.

Authors:  Anandalakshmi Venkatraman; Elavazhagan Murugan; Shu Jun Lin; Gary Swee Lim Peh; Lakshminarayanan Rajamani; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

7.  Genotypic Homogeneity in Distinctive Transforming Growth Factor-Beta Induced (TGFBI) Protein Phenotypes.

Authors:  Sang Beom Han; Venkatraman Anandalakshmi; Chee Wai Wong; Si Rui Ng; Jodhbir S Mehta
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

8.  pH Induced Conformational Transitions in the Transforming Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants.

Authors:  Elavazhagan Murugan; Anandalakshmi Venkatraman; Zhou Lei; Victoria Mouvet; Rayne Rui Yi Lim; Nandhakumar Muruganantham; Eunice Goh; Gary Swee Lim Peh; Roger W Beuerman; Shyam S Chaurasia; Lakshminarayanan Rajamani; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.